LUPKYNIS Drug-use Results Survey

Launched by OTSUKA PHARMACEUTICAL CO., LTD. · Jun 27, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how safe and effective the medicine LUPKYNIS is for people with lupus nephritis, a condition where lupus affects the kidneys. The study will collect information from patients who are starting to take LUPKYNIS in real-life settings, outside of a strict clinical environment. This helps doctors understand how the drug works and any side effects it might have when used in everyday medical care.

To take part, patients need to be newly starting treatment with LUPKYNIS for lupus nephritis. The study is open to adults of all genders, but it has not started recruiting participants yet. If you join, you can expect to share information about how well the medicine is working for you and any side effects you experience. This information will help improve knowledge about LUPKYNIS and support better treatment for people with lupus nephritis in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients who are newly starting administration of LUPKYNIS for lupus nephritis
• Exclusion Criteria:
• • -